4.4 Review

Structure, Functions and Selective Inhibitors of HDAC6

Journal

CURRENT TOPICS IN MEDICINAL CHEMISTRY
Volume 18, Issue 28, Pages 2429-2447

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568026619666181129141822

Keywords

Epigenetics; HDAC6; Protein degradation; Neurodegenerative disease; Cancer; HDAC6 selective inhibitors

Funding

  1. National Natural Science Foundation of China [21672127]
  2. Key Research and Development Project of Shandong Province [2017CXGC1401]
  3. Fundamental Research Funds of Shandong University [2016JC018]

Ask authors/readers for more resources

Histone deacetylases 6 (HDAC6) has emerged as a promising target for the treatment of various human diseases including cancer, neurodegenerative disease and immunology due to its unique structure, substrate and biological functions. HDAC6 is involved in cell motility, cell survival, cell cycle progression, developmental events, prognosis as well as protein degradation and the involvement of HDAC6 in multiple biological processes has gained lots of attention. There is increasing interest in HDAC6 and its selective inhibitors. More than twenty years of synthetic efforts have developed various HDAC6 selective inhibitors with different Cap, linker and ZBG. This review will summarize recent research data regarding HDAC6 and various HDAC6 selective inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available